HIGHLIGHTS
- who: Breast neoplasms and collaborators from the Hospital, Oncologia, Brazil have published the Article: Analysis of trastuzumab therapy’s efficacy with or without pertuzumab combination in the metastatic HER2-positive breast cancer an oncology hospital of Pernambuco, in the Journal: (JOURNAL)
- what: This study was relevant, despite its limitations, mainly because it was conducted in a hospital for cancer patient care and exclusively serves SUS users, whose exposure to risk factors is more prominent and differentiated than those who have access to private health services.
SUMMARY
The authors observed an improvement . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.